Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location

NCT04925583 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT04925583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04925583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location
Lead sponsor
University Hospital Heidelberg
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 1, 2021
Completion date
November 1, 2030
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer